Organon

Yahoo Finance • 11 days ago

Ocugen gets EU approval for Prolia and Xgeva biosimilars

[Biosimilars pharmaceutical drug bottle on blue background. A safe biological drug that work like biologic medicine. 3d illustration.] Carl Lokko/iStock via Getty Images * Shanghai Henlius Biotech (2696.HK) and Organon (NYSE: NYSE:OGN [... Full story

Yahoo Finance • 28 days ago

Organon and Henlius get FDA nod for Amgen biosimilars

[Biosimilars pharmaceutical drug bottle on blue background. A safe biological drug that work like biologic medicine. 3d illustration.] Carl Lokko/iStock via Getty Images Shanghai Henlius Biotech and Organon (NYSE:OGN [https://seekingalpha... Full story

Yahoo Finance • 2 months ago

Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors

EMERYVILLE, Calif., August 12, 2025--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Dr. Reginald Seeto and William... Full story

Yahoo Finance • 2 months ago

Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings

We recently published 10 Big Names Bleed Double Digits. Organon & Co. (NYSE:OGN) is one of the worst-performing stocks on Tuesday. Organon fell for a second day on Tuesday, shedding 13.13 percent to close at $8.4 apiece following a disapp... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: Organon Q2 2025 beats EPS expectations, stock volatile

Organon & Co reported its second-quarter 2025 earnings, surpassing analysts’ expectations with an EPS of $1.00, compared to the forecasted $0.94, marking a 6.38% surprise. The company also reported a revenue of $1.59 billion, exceeding the... Full story

Yahoo Finance • 2 months ago

Organon Q2 2025 slides: Revenue guidance raised amid Women's Health strength

Organon & Co (NYSE:OGN) shares jumped over 6% in premarket trading after the company’s Q2 2025 earnings presentation revealed raised revenue guidance and continued progress on debt reduction, despite ongoing challenges from loss of exclusi... Full story

Yahoo Finance • 2 months ago

Organon shares surge over 8% as Q2 earnings top estimates, raises revenue outlook

JERSEY CITY, N.J. - On Tuesday, Organon (NYSE:OGN) reported second-quarter earnings that exceeded analyst expectations and raised its full-year revenue guidance, while making significant progress on debt reduction. The healthcare company’... Full story

Yahoo Finance • 2 months ago

Organon & Co. Investors: Please contact the Portnoy Law Firm to recover your losses. July 22, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Organon & Co. ("Organon" or the "Company") (NYSE: OGN) investors of a... Full story

Yahoo Finance • 2 months ago

Contact Levi & Korsinsky by July 22, 2025 Deadline to Join Class Action Against Organon & Co.(OGN)

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses o... Full story

Yahoo Finance • 2 months ago

The Gross Law Firm Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline – OGN

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to contact t... Full story

Yahoo Finance • 2 months ago

OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. (“Organon” or “th... Full story

Yahoo Finance • 2 months ago

DEADLINE TOMORROW: Berger Montague Advises Organon & Co. (NYSE: OGN) Investors to Inquire About a Securities Fraud Class Action by July 22, 2025

PHILADELPHIA, July 21, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) on behalf of purchasers of Organon... Full story

Yahoo Finance • 2 months ago

DEADLINE ALERT for DV, OGN, RCAT, and FTRE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 21, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • 2 months ago

ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Organon & Co. Investors of Upcoming Deadline

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) investors of an upcoming deadline involving a securities... Full story

Yahoo Finance • 2 months ago

INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – OGN

SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities betw... Full story

Yahoo Finance • 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between Novembe... Full story

Yahoo Finance • 2 months ago

OGN SECURITIES NEWS: Did Organon & Co. (NYSE:OGN) Commit Securities Fraud? Contact BFA Law by July 22 Class Action Deadline

NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential vio... Full story

Yahoo Finance • 2 months ago

OGN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important July 22 Deadline in Securities Class Action – OGN

NEW YORK, July 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the “Cl... Full story

Yahoo Finance • 2 months ago

ORGANON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Organon (OGN) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between November 3... Full story

Yahoo Finance • 2 months ago

Organon & Co. Investors: Please contact the Portnoy Law Firm to recover your losses; July 22, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Organon & Co. ("Organon" or the "Company") (NYSE: OGN) investors of a... Full story